(Q35006445)

5 August 2017

title

Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia (English)

1 reference

5 August 2017

1 reference

Harold Bays

1

1 reference

5 August 2017

Nicola Abate

series ordinal

2

1 reference

5 August 2017

Manisha Chandalia

series ordinal

3

1 reference

5 August 2017

publication date

1 January 2005

1 reference

5 August 2017

1 reference

5 August 2017

volume

1

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

39-59

1 reference

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Prevalence of the metabolic syndrome in US populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Metabolic and body composition factors in subgroups of obesity: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Relationships of generalized and regional adiposity to insulin sensitivity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

LDL subclass phenotypes and the insulin resistance syndrome in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Body mass index and the prevalence of hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Human adipocytes secrete mineralocorticoid-releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Extended-release niacin/lovastatin: the first combination product for dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

FDA approach to the regulation of drugs for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

Oral antihypertensive trial design and analysis under the pediatric exclusivity provision

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796678.1.1.39

21 January 2018

Identifiers

DOI

10.1517/14796678.1.1.39

1 reference

5 August 2017

1 reference